Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies
Brunilda Alushi(Deutsches Herzzentrum der Charité), Alexander Lauten(German Centre for Cardiovascular Research), Herko Grubitzch(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Ulf Landmesser(Deutsches Herzzentrum der Charité), Amedeo Amedei(University of Florence), Lavinia Curini(German Centre for Cardiovascular Research), Mary Christopher(German Centre for Cardiovascular Research)
Cited by 82
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k